Rhenman & Partners Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,221	Closed	-$79K	–	110
2017 Q2	$79K	Hold	1,221	–	–	0.01%	106
2017 Q1	$115K	Hold	1,221	–	–	0.02%	102
2016 Q4	$89K	Hold	1,221	–	–	0.02%	108
2016 Q3	$137K	Hold	1,221	–	–	0.02%	107
2016 Q2	$128K	Hold	1,221	–	–	0.02%	97
2016 Q1	$93K	Hold	1,221	–	–	0.02%	92
2015 Q4	$97K	Hold	1,221	–	–	0.01%	96
2015 Q3	$820K	Hold	1,221	–	–	0.13%	90
2015 Q2	$814K	Hold	1,221	–	–	0.1%	95
2015 Q1	$818K	Hold	1,221	–	–	0.14%	87
2014 Q4	$641K	Buy	1,221 +484	+66%	+$242K	0.19%	83
2014 Q3	$439K	Hold	737	–	–	0.13%	96
2014 Q2	$481K	Sell	737 -454	-38%	-$301K	0.14%	93
2014 Q1	$936K	Sell	1,191 -324	-21%	-$263K	0.28%	82
2013 Q4	$1.17M	Buy	+1,515	New	+$1.14M	0.46%	75

Other funds holding MTEM

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rhenman & Partners Asset Management's MTEM Position: Q3 2017 in Review

Rhenman & Partners Asset Management sold out of Molecular Templates, Inc. (MTEM) in Q3 2017, closing a stake of 1,221 shares — an estimated $79K sold.

Rhenman & Partners Asset Management first reported a position in MTEM in Q4 2013 and held it in 15 quarters. The position peaked at $1.17M in Q4 2013. 29 funds tracked by Wall St. Rank hold MTEM as of Q3 2017.

Rhenman & Partners Asset Management reported no remaining Molecular Templates, Inc. position as of Q3 2017 after selling out during the quarter.
Rhenman & Partners Asset Management sold 1,221 Molecular Templates, Inc. shares in Q3 2017, an estimated $79K.
Rhenman & Partners Asset Management first reported a position in Molecular Templates, Inc. in Q4 2013 and held it in 15 quarters.
Rhenman & Partners Asset Management's Molecular Templates, Inc. position peaked at $1.17M in Q4 2013.
29 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2017.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.